Current Positions
-Clinical Assistant Professor in Division of Pulmonary and Critical Care Medicine, Department of
Internal Medicine, Seoul National University Bundang Hospital

Degrees
-Medical doctor: February 2011, College of Medicine, Seoul National University
-Specialist in Internal Medicine: February 2016, College of Medicine, Seoul National University
-Master of Medicine: February 2016, College of Medicine, Seoul National University

Internship
-March, 2011 ~ Feb. 2012: Seoul National University Hospital

Residency
-March, 2012 ~ Feb. 2016: Department of Internal Medicine, Seoul National University Hospital

Fellowship
-May, 2019 ~ Feb. 2020: Division of Pulmonary and Critical Care Medicine, Department of Internal
Medicine, Seoul National University Bundang Hospital

Professor John K Field PhD, FRCPath.

Director of Research, Roy Castle Lung Cancer Research Programme
The University of Liverpool
Department of Molecular and Clinical Cancer Medicine
Institute of Systems, Molecular & Integrative Biology
The William Duncan Building
6 West Derby Street, L7 8TX
LIVERPOOL, UK.

Email This email address is being protected from spambots. You need JavaScript enabled to view it.

Short Biography

Professor John Field has a Personal Clinical Chair in Molecular Oncology at the University of Liverpool. He is the Chief Investigator for the UK Lung Cancer Screening Trial (UKLS) and the principal investigator of the Liverpool Lung Project (LLP), a 21year molecular- epidemiological study into the early detection of lung cancer (~14,000 recruited). Development of Lung cancer risk prediction model, which have been used in the UKLS and National lung cancer screening implementation programmes. The UKLS and the LLP form part of the NCRI Lung Cancer portfolio. Currently co-applicant on the NIH U19 programme grant involving biomarkers, radiomics and risk-modelling; contributing to the lung cancer genetic susceptibility projects ‘Lung Oncoarray’ project with CIDR/USA. Also, long term involvement in the identification of molecular diagnostic markers in lung cancers; currently a major programme funded by Janssen.
His research funding has been provided mainly by the RCF, NWCRF, MRC, CRUK, EU, NIH HTA and Pharma.

https://www.liverpool.ac.uk/translational-medicine/staff/john-field/
https://liverpoollungproject.org.uk/
http://www.ukls.org/
https://orcid.org/0000-0003-3951-6365